The Role of Azilsartan in Achieving The New Blood Pressure Targets in Hypertension cv-live

About This Course

Flow of the CME Lecture:

15 mins : Presentation by Dr. Michael Weber

- Background to Hypertension 'HTN', its epidemiology,
- Why we treat HTN?
- What our treatment targets are?
- How an innovative drug like azilsartan is important in HTN treatment?
- Azilsartan's formulation and how it differs from other ARBs and it workings

15 mins : Presentation by Dr.Brian Pinto

Clinical data on the drug
Case-Study Approach

30 mins : Discussion and Q n A

Course Staff

Course Staff Image #1

Dr. Michael Weber

Professor of Medicine Department of Medicine (Cardiology) State University of New York Downstate College of Medicine, Brooklyn,USA

Course Staff Image #2

Dr. Brian Pinto

DM Cardiology, Chief Cardiologist at Holy Family Hospital, India.

  1. Course Number

  2. Classes Start

    Jun 23, 2017
  3. Classes End

    Jun 23, 2030